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Fucosylation of LAMP-1 and LAMP-2 by FUT1
correlates with lysosomal positioning and autophagic
flux of breast cancer cells
Keng-Poo Tan1,2, Ming-Yi Ho2, Huan-Chieh Cho2, John Yu2,3, Jung-Tung Hung2 and Alice Lin-Tsing Yu*,2,3,4
Alpha1,2-fucosyltransferases, FUT1 and FUT2, which transfer fucoses onto the terminal galactose of N-acetyl-lactosamine via
α1,2-linkage have been shown to be highly expressed in various types of cancers. A few studies have shown the involvement of
FUT1 substrates in tumor cell proliferation and migration. Lysosome-associated membrane protein 1, LAMP-1, has been reported
to carry alpha1,2-fucosylated Lewis Y (LeY) antigens in breast cancer cells, however, the biological functions of LeY on LAMP-1
remain largely unknown. Whether or not its family member, LAMP-2, displays similar modifications and functions as LAMP-1 has
not yet been addressed. In this study, we have presented evidence supporting that both LAMP-1 and 2 are substrates for FUT1, but
not FUT2. We have also demonstrated the presence of H2 and LeY antigens on LAMP-1 by a targeted nanoLC-MS3 and the
decreased levels of fucosylation on LAMP-2 by MALDI-TOF analysis upon FUT1 knockdown. In addition, we found that the
expression of LeY was substantial in less invasive ER+/PR+/HER− breast cancer cells (MCF-7 and T47D) but negligible in highly
invasive triple-negative MDA-MB-231 cells, of which LeY levels were correlated with the levels of LeY carried by LAMP-1 and 2.
Intriguingly, we also observed a striking change in the subcellular localization of lysosomes upon FUT1 knockdown from
peripheral distribution of LAMP-1 and 2 to a preferential perinuclear accumulation. Besides that, knockdown of FUT1 led to an
increased rate of autophagic flux along with diminished activity of mammalian target of rapamycin complex 1 (mTORC1) and
enhanced autophagosome–lysosome fusion. This may be associated with the predominantly perinuclear distribution of
lysosomes mediated by FUT1 knockdown as lysosomal positioning has been reported to regulate mTOR activity and autophagy.
Taken together, our results suggest that downregulation of FUT1, which leads to the perinuclear localization of LAMP-1 and 2, is
correlated with increased rate of autophagic flux by decreasing mTOR signaling and increasing autolysosome formation.
Cell Death and Disease (2016) 7, e2347; doi:10.1038/cddis.2016.243; published online 25 August 2016
Alpha1,2-fucosyltransferases (FUT1 and FUT2) are key
enzymes to catalyze the transfer of fucose onto the terminal
galactose of type 1 or type 2 disaccharide (Gal (β1,3 or 1,4)
GlcNAc-R) via α1,2-linkage,1,2 resulting in H type 1 (H1) or H
type 2 (H2) antigens. In general, FUT1 preferentially gen-
erates H type 2 antigens, whereas FUT2 shows preference for
H type 1.3 The H antigens can be further substituted by adding
a fucose onto the N-acetylglucosamine of type 1 or type 2
precursors in α1,4- or α1,3-linkage, giving rise to Lewis B (LeB)
and Lewis Y (LeY) antigens, respectively.4 The aberrant α1,2-
fucosylation is a hallmark of multiple types of cancers. Several
reports have demonstrated that overexpression of FUT1 is
associated with enhanced tumor cell proliferation and tumor-
igenicity, whereas silencing of FUT1 exerts the opposite
effects.5–8 In addition, the involvement of FUT1 in other cellular
processes such as adhesion,4,9 migration,10 apoptosis1 and
angiogenesis have also been demonstrated.11,12 Although the
importance of α1,2-fucosytransferase in cancer biology
processes has been reported, the molecular mechanisms
involved remains largely unclear. Thus, it is worthwhile to
identify the target proteins of α1,2-fucosytransferase and to
gain insight into their biological functions.
Lysosome-associated membrane protein 1 (LAMP-1) and
its family member LAMP-2 share 37% amino-acid sequence
homology and both are highly glycosylated type I transmem-
brane proteins with 18 and 16 potential N-linked glycosylation
sites, respectively. Both LAMP-1 and 2 are mainly found in the
lysosomes and late endosomes,13 and are known to maintain
the lysosomal acidification and lysosomal membrane
integrity.13,14 In addition to their role in lysosomal biogenesis,
it has also been reported that both LAMP-1 and 2 or LAMP-2
alone is associated with autophagosome accumulation and
biogenesis.15–17 The presence of extensive N-glycosylation
on both LAMP-1 and 2 has been suggested to protect them
from the lysosomal proteolysis.18,19 On the other hand, greater
levels of poly-N-acetyllactosamines20,21 on LAMP-1 and 2 are
correlated with decreased cellular differentiation22–24 and
enhanced metastatic potential.25,26 It has been suggested
that the terminal glycan residue, sLeX, on LAMP-1 and 2 is
involved in cellular adhesion, tumor invasion and metastasis
by binding to the E-selectin expressing endothelial cells,25,27
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whereas LeY termini on LAMP-1 are believed to be associated
with breast cancer cell migration.28 Although the expression of
LeY termini on surface LAMP-1 in breast cancer cells have been
reported to be 30-fold higher than that of non-tumorigenic
mammary epithelial cells,28 the presence of LeY on LAMP-2,
and the role of LeY in the biological functions of LAMP-1 and 2
remain to be delineated.
In this study, we have demonstrated that LAMP-1 and 2 are
target proteins for FUT1 but not FUT2. We have also
demonstrated that LeY antigens carried by LAMP-1 and 2 in
weakly invasive breast cancer cells are significantly more
abundant than those from highly invasive cancer cells.
Notably, we found that a more prominent perinuclear
accumulation of LAMP-1/2(+) vesicles in FUT1 knockdown
cells as compared with control cells with peripheral
distribution. More importantly, our results reveal that FUT1
knockdown, which leads to increased perinuclear positioning
of lysosomes, is accompanied by an increased autophago-
some–lysosome fusion and a decreased mTORC1 activity
that may, in turn, be associated with an increased rate of
autophagic flux.
Result
Both LAMP-1 and 2 are substrates of FUT1. It is known
that both LAMP-1 and 2 contain numerous putative
N-glycosylation sites and five (N shown in red in
Supplementary Figure S1a) of these sites are conserved
between LAMP-1 and 2. All of these N-glycosylation sites are
exclusively located in their luminal ectodomain. To examine
whether LAMP-1 is a target of α(1,2)-fucosytransferases,
FUT1 and FUT2 were transiently overexpressed in breast
cancer cell line T47D breast cancer cells in which the mRNA
expression of FUT1 and FUT2 was about ~ 8401 and ~ 5490-
fold of the control groups, respectively (Supplementary
Figure S2a). The transfected cells were then treated with
alkynyl fucose for 3 days followed by immunoprecipitation of
LAMP-1 for ‘On-Membrane Click Reaction.’ As shown in
Supplementary Figure S1b, the fucosylation of LAMP-1 with
different linkage types was detected in T47D cells over-
expressing either FUT1, FUT2 or control vector. Notably, the
extent of fucosylation on LAMP-1 in cells overexpressing
FUT1 was about 1.8-fold greater than those of the control,
Figure 1 LAMP-1 and 2 are substrates of FUT1. (a) Expression levels of LeYantigens on immunoprecipitated LAMP-1 and 2 from control, FUT1 and FUT2 knockdown cells.
Both LAMP-1 and 2 were immunoprecipitated from FUT1 and FUT2 silenced T47D cells and then immunobloted with antibodies against LeY. The same blots were stripped and
reprobed for LAMP-1 or LAMP-2. The ratios of LeY to immunoprecipitated LAMP-1 or LAMP-2 were quantified and fold changes relative to control were shown as indicated.
(b) Immunoblot analysis of LeY levels in MCF-7, T47D and highly metastatic MDA-MB-231 cells (left panel). Actin was used as loading control. Expression levels of LeYantigens
on immunoprecipitated LAMP-1 and 2 from MCF-7, T47D and MDA-MB-231 cells (right panel). LAMP-1 and 2 were immunoprecipitated from the indicated cells, and
immunobloted with anti-LeY, anti-LAMP-1 or anti-LAMP-2 antibodies used in (a)
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whereas the extent of fucosylation on LAMP-1 in cells
overexpressing FUT2 showed no significant difference. This
suggests that LAMP-1 may be a target protein for FUT1, but
not FUT2. In addition, T47D cells, which express both FUT1
and FUT2 activities, were treated with siRNA for FUT1 or
FUT2 to silence FUT1 or FUT2 expression, to 12.6% and
5.6%, respectively, of negative controls (Supplementary
Figures S2b and S1c). As expected, a significant decrease
of LeY levels on both LAMP-1 and 2 was only found in FUT1
knockdown cells, but not FUT2 knockdown cells, when
compared with the control cells (Figure 1a). This result
further confirms that both LAMP-1 and 2 can be modified by
FUT1 but not FUT2. Moreover, we also found that the
expression of LeY in less invasive MCF-7 and T47D cells
(ER and PR positive) was more abundant than that in the
invasive triple-negative MDA-MB-231 cells, and that the LeY
levels in these cells are closely correlated to the levels of LeY
carried by LAMP-1 and 2 (Figure 1b). Collectively, these
results suggest that FUT1, but not FUT2, is the main catalyst
for both LAMP-1 and 2, which regulates the levels of LeY
carried by LAMPs.
Mass spectrometric analysis shows a decrease in
terminal fucosylation on both LAMP-1 and 2 upon FUT1
knockdown. To analyze the changes in N-glycan profiles of
LAMP-1 and 2 upon FUT1 knockdown, the endogenous
LAMPs from T47D cells were immunoprecipitated and
separated by SDS-PAGE. The N-glycans were then enzy-
matically released by in-gel PNGase F treatment with
subsequent reduction and permethylation for MALDI-TOF
MS and nanoLC-MS/MS analysis. In MALDI-TOF profiles, the
major N-glycosylation structures found on LAMP-1 were high-
mannose (predominant) and complex-type (minor) N-glycans
(Figure 2a); whereas LAMP-2 showed predominantly com-
plex bisecting-type N-glycans (Figure 3; ions at m/z 2260). As
shown in Figure 2a, the complex-type N-glycans of LAMP-1
with either bi-, tri- or tetra-antennary structures exhibited high
levels of fucosylation (with up to four fucose residues) along
with relatively low levels of sialylation. However, fucosylation
on LAMP-2 with 2 to 3 fucoses were only found on the tri- and
tetra-antennary N-glycans. Although the complex type
N-glycans on LAMP-2 were relatively low as compared with
those of LAMP-1, a significant decrease in the extents of
fucosylation on LAMP-2 was still observed upon FUT1
knockdown (Figure 3). To characterize the terminal fucosy-
lated epitopes modified by FUT1, we further used a targeted
nanoLC-MS3 method to enable specific linkage analysis
and quantitation of the terminal fucosylated glycotopes
of N-glycans on LAMP-1. In this analysis, the complex
N-glycans of LAMP-1 were limited to bi-antennary structures
and to those with 1 to 3 fucose residues that were preset
as precursor ion candidates for data-dependent MS/MS
acquisition. Among the MS/MS product ions afforded by
fucosylated precursors, B-fragment ion at m/z 660.3 was
further selected for MS3 analysis to characterize the terminal
glycotopes. As shown in Figure 2b, the extracted ion
chromatogram (EIC) of m/z 826.7 for bi-antennary structures
with additional two fucose residues showed peak splitting at
retention time 23.8 and 24.3 min. The earlier peak was further
identified as bi-antennary structures with H type 2 glycotopes
by MS3 spectrum of fragment ions at m/z 415, 433 and
cross-ring fragment ions at m/z 503 (3,5A), whereas the later
peak was determined as Lewis X (LeX) glycotopes according
to the diagnostic ions at m/z 259, 454 and 329 (3,5A).
Comparison of the EICs for the representative bi-antennary
glycans of LAMP-1 among mock, control or FUT1 knockdown
cells revealed a significant difference in the intensities of
these peaks. Thus, our data clearly demonstrated that the
expression of H2 glycotopes on LAMP-1 was reduced in
FUT1 knockdown cells as compared with those of the mock
or control cells. Similar to the tandem mass analysis of H2
and LeX structural isomer, the B-fragment ions (m/z 834.4) in
MS/MS spectrum, which could only be found in bi-antennary
glycans with three fucose residues, was sijmilarly selected at
the retention time 24.1 min for MS3 analysis of LeY
glycotopes. The identification of LeY was mainly based on
diagnostic fragment ions at m/z 415, 433, 646 and cross-ring
fragment ions at m/z 503 (3,5A) in the MS3 spectrum. Similar
to H2 glycotopes, EIC of m/z 884.8 for the representative
glycans of LAMP-1 showed a decrease in the intensity of LeY
glycotopes upon FUT1 knockdown. This is consistent with
our result in Figure 1a that the expression of LeYon LAMP-1
was reduced upon FUT1 knockdown. Taken together, these
MS results further verified that FUT1 is responsible for the
terminal fucosylation of H2 and LeY found on both LAMP-1
and 2. Supplementary Table S1 summarizes the results of
fucosylation changes in LAMP-1 or LAMP-2 upon FUT1
knockdown detected by various analytical methods.
Downregulation of FUT1 leads to accumulation of
LAMP-1/2(+) vesicles at perinuclear area. Upon silencing
of FUT1 in MCF-7 and T47D breast cancer cells, we observed
a striking change in the subcellular distribution patterns of
LAMP-1 and 2 by immunofluorescence staining. As shown in
Figure 4a, LAMP-1 staining in the control cells appeared as
vesicle-like structures and distributed randomly in the
cytoplasm. In contrast, LAMP-1(+) vesicles in FUT1 knock-
down cells mostly accumulated in the perinuclear region.
Quantitative analysis showed that the proportion of cells with
predominantly perinuclear LAMP-1(+) vesicles increased from
17.16±0.1% and 52.27±5.3% in control MCF-7 and T47D
cells, respectively, to 61.39±3% and 87.93±4.4% in FUT1
silenced MCF-7 and T47D cells (P=0.0001, P=0.0068),
respectively. As expected, the perinuclear-dominant distribu-
tion of LAMP-1 upon FUT1 knockdown was also observed in
LAMP-2(+) vesicles, which colocalized with LAMP-1, as seen
in the control cells (Figure 4b). In addition, LAMP-1/2(+)
vesicles in FUT1 knockdown cells tended to cluster together
leading to larger lysosomal vesicles as compared with control.
Here, we also stained the T47D cells with a lysosomotropic
dye acridine orange to characterize the changes in the
distribution of LAMP-1/2(+) vesicles. As shown in
Supplementary Figure S3, those vesicle structures observed
in both control and FUT1 knockdown cells exhibited char-
acteristics of acidic lysosomal compartments with orange red
signals. Thus, the altered distributions of LAMP-1 and 2 upon
FUT1 knockdown could reflect the changes of lysosomal
positioning. Taken together, these results suggest that FUT1
silencing alters both the morphology and positioning of
FUT1-modified LAMPs correlate with autophagic flux
K-P Tan et al
3
Cell Death and Disease
FUT1-modified LAMPs correlate with autophagic flux
K-P Tan et al
4
Cell Death and Disease
lysosomes with relocalization of the enlarged LAMP-1/2(+)
vesicles to the perinuclear region.
Downregulation of FUT1 is correlated with an increased
rate of autophagic flux. It has been reported that lysosomal
positioning could regulate the initiation and termination
stages of autophagic flux.29,30 Thus, to further investigate
the consequence of lysosomal positioning mediated by
FUT1, we first examined the autophagic process in FUT1
knockdown cells. As shown in Figure 5, the levels of LC3-II
increased to 1.92±0.11 (P= 0.013) and 1.54±0.01-fold
(P= 0.0005) of control cells in FUT1 knockdown MCF-7 and
T47D cells, respectively. However, the levels of autophagic
substrate p62 decreased to 0.63±0.02 (P= 0.004)
and 0.41± 0.03-fold (P=0.002) of control cells in FUT1
knockdown MCF-7 and T47D cells, respectively. On the other
hand, we also measured the turnover of LC3-II in control and
FUT1 knockdown cells with or without lysosomal inhibitor
chloroquine (CQ). As shown in Supplementary Figure S4,
autophagosome accumulation with CQ resulted in enhanced
levels of LC3-II in both control and FUT1 knockdown cells
but it was more pronounced in FUT1 knockdown cells.
Taken together, our results suggest that FUT1 knockdown
is probably associated with an increase in the rate of
autophagic flux. To determine whether FUT1 exerts effect
on autophagosome–lysosome fusion, we next examined the
extent of colocalization of the endogenous LC3 (autophago-
somal marker) with LAMP-1 (a representative of lysosomal
compartment) in FUT1 knockdown cells. As shown in
Figure 6b, the colocalization of LC3 puncta with LAMP-1 in
Figure 2 Characterization of N-glycans on purified LAMP-1. (a) MALDI-TOF mass spectrum of permethylated N-glycans of LAMP-1 expressed in mock-treated T47D cells.
The insert graph showed full range MS spectrum with predominant high-mannose and minor complex-type N-glycans on LAMP-1 glycoproteins. The bi-, tri- and tetra-antennary
complex N-glycans of LAMP-1 were highly fucosylated with up to four fucose residues attached. The colored symbol and nomenclature for glycan structure follow the designation
of Consortium for Functional Glycomics (http://www.functionalglycomics.org/static/consortium/Nomenclature.shtml). (b) LC-MS3 analysis of bi-antennary N-glycans of LAMP-1
from control and FUT1 knockdown T47D cells. The EICs in the left panel showed the sodiated molecular ions of bi-antennary N-glycans carried with one (m/z 1141.6, [M+2Na]2+),
two (m/z 826.7, [M+3Na]3+) or three (m/z 884.8, [M+3Na]3+) fucose residues of purified LAMP-1 from mock, control or FUT1 knockdown cells. The EICs were reconstructed by ion
intensities within 20 p.p.m. accuracy of theoretical mass value. The major fragment ions of H type 2 (H2), Lewis X (LeX) and LeY glycotopes are schematically illustrated on the
right panel. Notably, those bi-antennary N-glycans with distinct terminal glycotopes were eluted at different retention times (RTs). The fragmentation was annotated according to
the Domon and Costello nomenclature54
Figure 3 MALDI-TOF mass spectra of complex N-glycan from purified LAMP-2 expressed in control and FUT1 knockdown T47D cells. The changes of fucosylation level on
tri- and tetra-antennary N-glycans were illustrated as relative abundance of each glycoform (as shown in different shades of gray boxes). Notably, the levels of fucosylation
decreased in both tri- and tetra-antennary N-glycans of LAMP-2 in FUT1 knockdown cells as compared with that in control cells. The molecular ions representing complex glycans
with degree of fucosylation were highlighted in the lower spectrum as red peaks at m/z 2709, 2883 and 3057 for tri-antennary and m/z 3158, 3332 and 3506 for tetra-antennary
N-glycans, respectively. The relative ratio of each glycoform is given in percentage of total sum of peak intensities of tri- and tetra-antennary glycans in the MS spectra. The
colored symbol and nomenclature for glycan structure are based on the designation of Consortium for Functional Glycomics as described in Figure 2a. Peaks labeled with
asterisks represent polyhexose ladder contaminations that were negligible for overall analysis
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Figure 4 Downregulation of FUT1 leads to accumulation of LAMP-1/2(+) vesicles at perinulear area of MCF-7 and T47D cells. (a) Immunofluorescence staining for LAMP-1
in control and FUT1 knockdown cells with anti-LAMP-1 (green) and Hoechst (nucleus, blue). Stained cells were then analyzed by confocal microscopy at × 63 magnification
(MCF-7 cells) and × 100 magnification (T47D cells). Scale bars, 10 μm. Histogram shows the percentage of control (black bars) and FUT1 knockdown (white bars) cells with
predominantly perinuclear localization of LAMP-1. Data shown are the mean± S.E.M. of three independent experiments (***Po0.001; **Po0.01). (b) Colocalization of LAMP-1
and 2 in perinuclear area of FUT1 knockdown MCF-7 and T47D cells. Control and FUT1 silenced T47D/MCF-7 cells were co-stained with anti-LAMP-1 (green) and anti-LAMP-2
(red), and nuclei were stained with Hoechst (blue). Colocalization was visualized by confocal microscopy at × 63 magnification (MCF-7 cells) and × 100 magnification (T47D cells)
with 3X optical zoom. Representative colocalization signals were shown in the merged image as yellow. Scale bars, 10 μm
FUT1-modified LAMPs correlate with autophagic flux
K-P Tan et al
6
Cell Death and Disease
control MCF-7 cells is only 26.4± 5.4% as compared with
approximately 60.9± 8.2% colocalization in FUT1 knockdown
cells (P=0.025), suggesting that knockdown of FUT1 could
facilitate the fusion of autophagosomes and lysosomes to
form degradative autolysosomes. It is noted that the LC3
puncta and LAMP-1 in FUT1 knockdown cells preferentially
colocalized at perinuclear region. This further supports the
previous notion that the emergence of perinuclear lysosomes
may increase their accessibility for the autophagosomes to
form autophagolysosomes.30
Downregulation of FUT1 is associated with decreased
mTORC1 activity. As lysosomal positioning has been
reported to coordinate mTORC1 activity,30,31 we thus
examined whether knockdown of FUT1, which increased
perinuclear lysosomes, was associated with a decrease in
mTOR activity. As shown in Figure 6a, the phosphorylation
status of p70 S6 kinase relative to the total S6K was reduced
to 0.28±0.09 (P= 0.015) and 0.6±0.05-fold (P= 0.014) of
the control cells in FUT1 knockdown MCF-7 and T47D cells,
respectively, indicating suppression of mTOR activity upon
FUT1 silencing. This was also confirmed with a time kinetic
study of mTOR activity in which the activity of mTOR began to
decline at 72 h after downregulation of FUT1 and continued
to drop up to 120 h. Notably, the increase in LC3-II became
evident at 72 h and continued to rise up to 120 h, whereas the
Figure 5 Knockdown of FUT1 is associated with an increase in autophagic flux. (a) Immunoblot analysis of LC3-II and p62 levels in control and FUT1 knockdown cells. Total
cell lysates from MCF-7 and T47D cells transfected with control or FUT1 siRNAswere collected at 120 and 96 h post-transfection, respectively. Equal amounts of cell lysates were
then loaded in each lane and separated by SDS-PAGE. Immunoblot analysis was performed with LC3 and p62 antibodies. Actin was used as a loading control. The intensity of
LC3-II and p62 protein bands on immunoblot were quantified and normalized to actin, and the relative levels of protein expression were expressed as fold change by setting the
control group value to 1. Values shown are mean± S.E.M. of three independent experiments (***Po0.001; **Po0.01; *Po0.05). (b) Downregulation of FUT1 enhanced the
fusion of autophagosome and lysosomes in MCF-7 cells. Cells were co-stained with anti-LAMP-1 (green) and anti-LC3 (red) and nuclei stained with Hoechst (blue).
Representative colocalization signals (referred to as autolysosomes) were shown in yellow in the merged. Magnification × 63, zoom: × 3. Scale bars, 10 μm. Histogram shows the
percentages of autolysosomes (LC3+/LAMP-1+) to autophagosomes (LC3+/LAMP-1−). Data are mean± S.E.M. of three independent experiments of 4100 cells per group
(*Po0.05)
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levels of LAMP-1 and 2 remained unchanged throughout this
time course (Figure 6b). To further define the correlation
between mTOR activity and autophagy upon FUT1 knock-
down, LC3-II levels in control and FUT1 knockdown cells
were evaluated in the presence or absence of rapamycin
alone or in combination with CQ. As shown in Supplementary
Figure S4, autophagy activation with rapamycin was induced
significantly in control cells with increased levels of LC3-II,
whereas FUT1 knockdown had only modest effects. Upon
treatment with both rapamycin and CQ, the levels of LC3-II in
control and FUT1 knockdown cells were further elevated but
more pronounced in FUT1 knockdown cells, suggesting the
inhibitory effect of FUT1 on autophagic flux is partially attributed
to mTOR activity. As the peripheral localization of lysosomes is
reported to be associated with increased mTORC1 activity by
bringing it to cell membrane Rheb activator,30,32,33 we thus
further examined the distribution of mTOR in control and FUT1
knockdown cells. As shown in Supplementary Figure S5,
mTOR together with LAMP-1 appeared to be accumulated at
perinuclear region upon downregulation of FUT1, suggesting
that the perinuclear positioning of mTORC1 may discourage
its access to upstream signaling molecules, thereby decreas-
ing its activity. Taken together, these results suggest that
knockdown of FUT1 would facilitate the perinuclear accumula-
tion of lysosomes, which is accompanied by diminished mTOR
signaling and enhanced autophagic flux.
Discussion
In this study, we combined the biochemistry, MALDI-TOF MS
and nanoLC-MS3 analysis to characterize the alpha1,2-
fucosylation on both LAMP-1 and 2 in breast cancer cells.
Differing from the report of Jacques et al. that LAMP-1 is
identified as a carrier for LeY antigens, our study has
additionally demonstrated the presence of H2 and LeY
antigens on LAMP-1 is mediated by FUT1 but not FUT2.
Similarly, we have also identified the LAMP-1 family member,
LAMP-2, as a novel substrate of FUT1 with LeY moiety
attached. Topographically, we have discovered a striking
change in the subcellular localization of LAMP-1 and 2 upon
FUT1 knockdown in which LAMP-1 and 2 were preferentially
accumulated at perinuclear region rather than being at the
peripheral region, as seen in the control cells. On the other
hand, we have found that knockdown of FUT1 results in an
increased rate of autophagosome formation and degradation,
which is accompanied by a decrease in mTORC1 (a known
suppressor of autophagy) activity and an increase in
autophagosome–lysosome fusion. As lysosomal positioning
has been reported to coordinate mTOR activity and autop-
hagy, the enhancement of autophagic flux in FUT1 knockdown
cells appears to be the result of decreased mTOR signaling
and increased autolysosome formation. Although LeY carried
by surface LAMP-1 has been suggested to be involved in cell
migration in breast cancer,28 no studies so far showing the
correlation of FUT1-modified LAMP-1 and/or LAMP-2 with
lysosomal localization and autophagic process. Thus, this is
the first report to provide evidence for the involvement of FUT1
in the topographical distribution of LAMP-1 and 2 that
subsequently influences the autophagic activity and process
of breast cancer cells.
In normal cells, most of the LAMP-1 and 2 are found in the
lysosomes and late endosomes that are localized perinu-
clearly; while a small fraction of the LAMP-1 and 2 is found to
shuttle between plasma membrane, endosomes and lyso-
somes dynamically.34,35 However, in cancer cells, especially
those with invasive phenotype, the distribution of lysosomes
appears to shift from perinuclear to peripheral pattern for the
release of lysosomal contents to facilitate their migration/
invasion or metastasis.36,37 In our study, we have found that
the majority of LAMP-1 and 2 in FUT1 knockdown breast
cancer cells tends to localize at the perinuclear region rather
Figure 6 Knockdown of FUT1 is associated with decreased mTORC1 activity.
(a) Representative immunoblots and quantitative analysis of mTOR activity in control
and FUT1 knockdown cells. Lysates of MCF-7 and T47D cells transfected with control
or FUT1 siRNAs were subjected to immunoblot analysis with antibodies against
phospho-p70 S6K (Thr389) and total S6K. The resulting immunoblot bands were then
quantified and computed as phospho-p70 S6K/total S6K ratio for mTOR activity.
Values shown are mean fold change± S.E.M. of three independent experiments
(*Po0.05). (b) Time course of mTORC1 activity in control and FUT1 knockdown
MCF-7 cells. mTOR activity was determined by immunoblot analysis for the
phosphorylation status of p70 S6K from 48 to 120 h after FUT1 knockdown. Levels of
LAMP-1, LAMP-2 and LC3-II were analyzed in parallel over the indicated time points
and actin was used as a loading control. Results are representative of two
independent experiments
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than the cell periphery. Given that LAMPs are required for
regulating the motility of lysosomes through dynein-mediated
transport along microtubules,38,39 it is plausible that the lack of
α1,2-fucosylation may alter the integrity of LAMPs, which in
turn may affect the dynamic distribution of lysosomes. In
addition to lysosomal biogenesis, both LAMP-1 and 2 are also
known to participate in autophagic pathway in which knockout
of both LAMP-1 and 2 or LAMP-2 alone would result in a
massive accumulation of autophagosomes.15 However, the
enhanced autophagic flux found in our study could not be
ascribed to the changes in the expression levels of LAMP-1
and 2 because knockdown of FUT1 failed to significantly alter
their protein levels. Taken together, it is more likely that FUT1,
which targets LAMP-1 and 2, may exert considerable impact
on the positioning of lysosomes as well as the process of
autophagy through modification of alpha1,2-fucosylated anti-
gens on these LAMP molecules. However, the possibility
cannot be excluded that under-fucosylation of some other
target proteins may also participate in these processes.
To date, many factors that participate in the regulation of
lysosomal distribution or autophagy have been identified. The
preferential accumulation of lysosomes at perinuclear area
mainly occurs in the context of starvation and high intracellular
pH,29,30 whereas the induction of autophagy generally occurs
in response to nutrient deprivation, and metabolic and/or
cellular stress.40–42 Recently, Hyung et al. has reported that
treatment with the inhibitor of N-glycosylation, Tunicamycin,
resulted in the accumulation of perinuclear lysosomes as well
as the induction of autophagy.43 This is consistent with the
report of Qin et al. that Tunicamycin negatively regulates the
mTOR signaling pathway and induces autophagy.44 However,
the specific glycosyltransferases or glycans involved in these
cellular processes have yet to be identified in the above-
mentioned studies. In this study, the suppression of FUT1,
which directs the synthesis of terminal α1,2-fucosylation on
N-glycan backbones, exhibits a very similar phenomenon as
observed in Tunicamycin treatment. This implies that α1,2-
fucosylation alone may be sufficient for modifying lysosomal
topography and autophagic process. On the other hand,
hypoxic stress is known to be an important upregulator for the
induction of autophagy by a HIF-α1-dependent manner.45,46
Considering that HIF-α1 has been recently reported by Ana
et al. as an upstream repressor of FUT1 expression in
pancreatic tumors,47 our identification of the role of FUT1 in
autophagy may provide a coherent link between these two
findings.
Previously, Jacques et al. reported that the presence of
α1,2-fucosylated antigens (A, B, H, LeB and LeY) appeared to
confer tumor growth advantages during the early stage of
tumor progression.48 Besides, the involvement of α1,2-
fucosylation in a variety of malignant processes have also
been demonstrated. However, only a handful of reports has
attempted to elucidate the molecular mechanism involved in
these processes. In our study, the finding that α1,2-fucosyla-
tion contributes to autophagic flux may provide a link to the
tumorigenesis, as reduced autophagy is found in tumor
cells and is thought to be associated with malignant
transformation.49,50 In addition, the role of autophagy in tumor
suppression by preventing the accumulation of damaged
organelles and macromolecules49,51 further supports our
notion that the positive impacts of α1,2-fucosylation on
tumorigenesis may be partially attributable to its negative
effect on autophagy. Although it is known that the α1,2-
fucosylated LeY antigens can promote cell proliferation and
tumorigenesis by activating EGFR/MAPK signaling,52,53 our
finding may offer yet another pathway in which α1,2-
fucosylated LAMP-1 and 2 may regulate autophagy biogen-
esis, thereby influencing tumor development and progression.
In conclusion, this study has provided the first evidence for a
negative impact of FUT1 on autophagic flux in breast cancer
cells through its influence on lysosomal positioning. Given the
inhibitory effects of autophagy on cell proliferation and tumor
development, our work not only provide an alternative
mechanism of FUT1-mediated tumorigenesis but also a new
perspective on the interplay among α1,2-fucosylation, autop-
hagy and tumorigenesis. More importantly, this finding may
yield a strong scientific rationale for the future development of
FUT1 inhibitor for cancer therapy.
Materials and Methods
Reagents and antibodies. Mouse monoclonal antibodies against the human
LAMP-1 and 2 were purchased from BD Pharmingen (San Diego, CA, USA;
1 : 2000 dilution) and Santa Cruz Biotechnology (Santa Cruz, CA, USA; 1 : 1000
dilution), respectively. Alexa Fluor 488 mouse anti-human LAMP-1 (for IF staining)
was purchased from 53–1079, eBioscience (Vienna, Austria; 1 : 50 dilution). Rabbit
polyclonal anti-human LC3 and anti-p62 antibodies were from NBP1–48320
(1 : 1000 dilution) and NBP100–2331 (1 : 500 dilution) Novus Biological (Littleton,
CO, USA), respectively. Mouse anti-human LeY IgM was from ab3359, Abcam
(Cambridge, UK; 1 : 1500 dilution). Rabbit anti-p70 S6K and mouse anti-phospho-
p70 S6K (Thr389) were from #9202 and #9206 Cell Signaling (Danvers, MA, USA;
1 : 1000 dilution), respectively. Control mouse IgG1 antibodies were purchased from
R&D Systems (Minneapolis, MN, USA) as an isotype control. AP-conjugated goat
anti-mouse IgG and IgM, and streptavidin were obtained from Jackson
ImmunoResearch Laboratories (West Grow, PA, USA). Alexa Fluor 488 goat anti-
mouse IgG (H +L), Alexa Fluor 594 goat anti-mouse IgG (H +L), Alexa Fluor 594
goat anti-rabbit IgG (H +Land Alexa Fluor 647 goat anti-mouse IgG (H +L) were
from Invitrogen (Carlsbad, CA, USA),
Cell culture and siRNA transfection. Human breast cancer cell line T47D
purchased from American Type Culture Collection (ATCC, Manassas, VA, USA) was
maintained in RPMI-1640 medium (Gibco, Grand Island, NY, USA) supplemented
with 10% FBS and 2 mM Glutamax. MCF-7 (a gift from Michael Hsiao, GRC,
Academia Sinica) and MDA-MB-231 cells were grown in Dulbecco’s modified
Eagle's medium (Gibco) supplemented with 10% FBS and 2 mM Glutamax. For
FUT1 siRNA transfection, T47D cells were seeded into six-well plates at a density of
2 × 105 cells per well and cultured overnight. Cells were then transfected with FUT1
siRNA using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s
instructions. FUT1 siRNA and a scrambled negative control with equivalent GC
content (high duplex #2) were synthesized and annealed by Invitrogen. The FUT1
siRNAs used in this work were HSS177655 (sense 5′-AUUAAUGCCCACCCACU
CGGGCAGG-3′ and anti-sense 5′-CCUGCCCGAGUGGGUGGGCAUUAAU-3′)
and HSS103859 (sense 5′-AAGGCUUAGCCAAUGUCCAGAGUGG-3′ and anti-
sense 5′-CCACUCUGGACAUUGGCUAAGCCUU-3′).
Immunoprecipitation and immunoblotting. Cells were harvested and
lysed in lysis buffer (1% Triton X, 20 mM Tris-HCl pH 7.0, 5 mM EDTA, 50 mM
NaCl) and 1X complete EDTA-free protease inhibitor mixture (Roche, Basel,
Switzerland) followed by centrifugation at 15 000 × g for 15 min at 4 °C to remove
the cell debri. The supernatants of the cell lysates were then collected and protein
concentrations were determined by BCA Protein Assay Kit (Pierce, Rockford, IL,
USA). For immunoprecipitation of LAMP-1 and 2, 1 mg of the total lysates were
incubated with 2 μg of anti-LAMP-1 or anti-LAMP-2 antibody overnight at 4 °C with
gentle rocking followed by 1- h incubation with 50 μl of protein G-Sepharose 4 Fast
(GE Healthcare Life Sciences, Buckinghamshire, UK) at 4 °C. The immunopreci-
pitated samples were then run on 4–12% NuPAGE (Invitrogen) and electrophor-
etically transferred to a PVDF membrane for immunoblotting. The blots were probed
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with primary and AP-conjugated secondary antibodies for 1 h each, and
immunoreactive bands were visualized using ECF substrate (GE Healthcare Life
Sciences). All western blot images were acquired by Typhoon FLA 9500
(GE Healthcare Life Sciences) and intensity of the bands was quantified by
ImageQuant 5.2 (GE Healthcare Life Sciences).
On-membrane click reaction. The respective control vector, FUT1 or FUT2
transfectants were fed with fucose alkyne (kindly provided by Dr Chi-Huey Wong,
Academia Sinica, Taiwan) for 3 days. The metabolically labeled cells were
harvested, lysed and subjected to immunoprecipitation of the LAMP-1 as described
above. The immunoprecipitated LAMP-1 was then separated on 4–12% NuPAGE
and transferred to PVDF membranes. The blots were blocked with 3% BSA in PBST
buffer for 1 h at RT followed by a click reaction with a mixture of 0.1 mM azido
biotin, 0.1 mM Tris-triazoleamine catalyst, 1 mM CuSO4 and 2 mM sodium
ascorbate for another 1 h at RT. After this, the membrane was detected by probing
with AP-conjugated streptavidin.
In-gel PNGase F/tryptic digestion. Purified LAMP-1 were run on SDS-
PAGE and stained with Coomassie blue R250. The corresponding protein bands
were then excised from the gel and degylcosylated by in-gel PNGase F treatment.
For in-gel PNGase F digestion, the gel slices were first reduced with 10 mM DTTat
60 °C for 1 h and alkylated with 55 mM iodoacetamide at RT for 1 h followed by
soaking with one unit of PNGase F (P0705L, New England Biolabs, Ipswich, MA,
USA) in 25 mM ammonium bicarbonate buffer at 37 °C overnight. Afterward,
N-glycans were extracted two times with pure water and 50% acetonitrile per each.
All extracts were pooled together and concentrated by a SpeedVac. The remaining
gels were further digested with 12.5 ng/μl trypsin (V5111 Promega, Madison, WI,
USA) in 25 mM NH4HCO3 buffer and incubated overnight at 37 °C. The peptide
fragments extracted from gels were used for peptide mapping.
N-glycan derivatization and MS analysis. In order to increase MS
detection sensitivity with predictable fragmentation pattern and to prevent
chromatographic peak splitting because of the anomeric configuration of reducing
sugar, the in-gel PNGase F released N-glycans were subjected to reduction and
permethylation before MALDI-MS profiling and nanoLC-MS/MS analysis. Briefly, the
released N-glycans were reduced in 50 μl of 1.0 M NaBH4/0.05 N NaOH at 45 °C
for 2 h. The reaction was quenched by adding drops of glacial acetic acid until no
bubbles formation. The reduced N-glycan alditols were desalted by passing through
Dowex cation exchange resins and recovered from excess of boric acid by
co-evaporation with 1 ml of 10% (v/v) acetic acid in methanol for three times.
Permethylation was carried out by the NaOH/DMSO slurry method at room
temperature for 30 min. The permethylated derivatives were recovered by
using CHCl3/water extraction method. MALDI-TOF MS profiling of the derivatives
were carried out in positive-ion mode on a AB Sciex 5800 MALDI-TOF/TOF mass
spectrometer (Applied Biosystems, Foster City, CA, USA) using 2, 5-dihydro-
xybenzonic acid as the MALDI matrix.
NanoLC-MS/MS analyses of the permethylated N-glycan alditols were carried out
on a homemade nanoLC system consisted of a 50 μm× 4 cm homemade
polystyrene-divinylbenzene (PS-DVB) monolithic trap column and a 20 μm× 4 m
homemade PS-DVB grafted open tubular analytical column, coupled to Orbitrap Elite
(Thermo Scientific, Waltham, MA, USA) MS system. For this nanoLC system, sample
was dissolved in 2 μl of 25% (v/v) acetonitrile, injected to trap column and then
separated in a serially connected analytical column at a constant flow rate of
150 nl/min, with a linear gradient of 10–40% (v/v) acetonitrile (with 0.5 mM sodium
acetate) in 30 min, then increased to 80% acetonitrile in 5 min and held isocratically
for another 10 min. The eluent was directly interfaced to a nanospray source based
on the liquid junction configuration consisted of an uncoated emitter and a high
voltage (in range of 1.5–1.8 kV) platinum electrode. For data-dependent acquisition,
the full scan MS spectrum (m/z 500–2000) was acquired in the Orbitrap at 60 000
resolution (at m/z 400) with automatic gain control (AGC) target value of 5 × 106.
Data-dependent acquisition was performed for the 10 most intense ions within the
inclusion MS list with intensity threshold of 3000 counts. Subsequently, product-ion
dependent CID-MS3 experiments were carried out using two distinct B-fragment ion
candidates at m/z 660.32 and 834.41, with intensity threshold of 100 counts, within 25
most intense ions in MS2 spectra. The fragment ion assignment of MS/MS spectra was
depicted according to the Domon and Costello nomenclature and interpreted manually.
Immunofluorescence microscopy. Cells transfected with control and
FUT1 siRNA were fixed with 4% paraformaldehyde for 30 min, permeabilized with
0.1% Triton X-100 at room temperature for 15 min and blocked with 1% BSA in PBS
for 1 h. The permeabilized cells were incubated with primary antibodies overnight at
4 °C followed by the secondary antibodies for 1 h at room temperature. For double/
triple immunofluorescence staining, the sequential staining procedure started with
the unlabeled primary antibodies, followed by their corresponding secondary
antibodies, and subsequently with the directly conjugated antibodies. Between the
sequential staining steps, samples were washed in PBS containing 0.1% Triton
X-100 and blocked with 1% BSA. Cell nuclei were visualized by counterstaining with
Hoechst 33342. The immunostained samples mounted with Vectashield (Vector
Laboratories, Burlingame, CA, USA) were examined under a TCS SP8 confocal
microscopy (Leica, Wetzlar, Germany). Fluorescence images were acquired with
LAS AF Software (Leica).
Quantification of lysosomal distribution. As previously described,30 the
intracellular distribution of lysosomes can be divided into two main groups that are
defined as peripheral- and perinuclear-dominant lysosomal distribution if450% of
LAMP-1(+) vesicles localized in peripheral and perinuclear region, respectively. To
evaluate the proportion of cells with these two distribution patterns, cells stained for
LAMP-1 in 7–10 random fields were classified and counted. Note that LAMP-1-
positive vesicles were referred to as lysosomes and the data were expressed as the
percentage of cells with peripheral-dominant lysosomal localization and normalized
to control group. Quantification was carried out on approximately 80–100 cells per
sample group from two to three independent experiments.
Quantification of LC3 and LAMP-1 colocalization. Cells transfected
with control and FUT1 siRNA were co-immunostained for endogenous LAMP-1 and
LC3 as described above in immunofluorescence microscopy assay. Seven to 10
fields of each sample were selected randomly and captured under a TCS SP8
confocal microscopy. To analyze the colocalization between LC3 and LAMP-1, a
constant threshold between two channels of confocal images was applied and the
integrated pixel intensity of colocalization regions was quantified using the Measure
Colocalization in MetaMorph software (version 7.8.4.0) (Molecular Devices,
Sunnyvale, CA, USA). All values were expressed as the percentage of LC3/
LAMP-1 colocalization to the total number of LC3 puncta, and subsequently
normalized to the control for comparison. Quantification was carried out on
approximately 30 cells per sample group from three independent experiments.
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